Medicine Hat, Canada

Les P Nagata


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Les P. Nagata

Introduction: Les P. Nagata is an esteemed inventor based in Medicine Hat, Canada, with a significant contribution to the field of medical science. His innovative work focuses on utilizing liposome-encapsulated ciprofloxacin as a promising immunotherapeutic drug that has the potential to change treatments for various conditions.

Latest Patents: Les P. Nagata holds one patent titled "Use of Liposome Encapsulated Ciprofloxacin as an Immunotherapeutic Drug." This patent highlights the efficacy of liposome-encapsulated quinolones, particularly ciprofloxacin, which markedly enhances macrophage functions. The invention induces nitric oxide (NO) production and increases the levels of cytokines, positioning it as an immunoprophylactic and immunotherapeutic agent with outstanding clinical potential. This formulation could prove to be invaluable in antimicrobial, anticancer, and AIDS therapies, particularly for patients whose immune systems are compromised.

Career Highlights: Les is associated with the Minister of National Defence of Her Majesty's Canadian Government. In this prominent role, he applies his inventive spirit to contribute to advancements in medical science that can benefit a broad array of patients, particularly those facing critical health challenges due to compromised immunity.

Collaborations: Throughout his career, Les has worked alongside notable colleagues such as Jonathan P. Wong and Edward G. Saravolac. Their collaborative efforts have undoubtedly enriched the research landscape in which they operate, fostering innovation and progress within the medical field.

Conclusion: Les P. Nagata's contributions to medical science through his innovative patent represent a significant stride towards developing effective therapies for individuals battling critical health challenges. With the potential applications of liposome-encapsulated ciprofloxacin in various therapeutic contexts, Nagata's work exemplifies the importance of innovation in enhancing healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…